S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
Closing prices for crude oil, gold and other commodities
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
The Bottom Is In For Accenture
Jet pitched wildly, killing 1, amid cockpit warnings: NTSB
Bank Accounts: Frozen! (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Bank failures and rescue test Yellen's decades of experience
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
Closing prices for crude oil, gold and other commodities
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
The Bottom Is In For Accenture
Jet pitched wildly, killing 1, amid cockpit warnings: NTSB
Bank Accounts: Frozen! (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Bank failures and rescue test Yellen's decades of experience
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
Closing prices for crude oil, gold and other commodities
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
The Bottom Is In For Accenture
Jet pitched wildly, killing 1, amid cockpit warnings: NTSB
Bank Accounts: Frozen! (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Bank failures and rescue test Yellen's decades of experience
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Dividend King Genuine Parts Company Upgraded On Profit Guidance
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
11 Best Consumer Discretionary Stocks of 2023
Closing prices for crude oil, gold and other commodities
Free Stock Analysis Report: Invest Smarter With Powerful Data (Ad)pixel
The Bottom Is In For Accenture
Jet pitched wildly, killing 1, amid cockpit warnings: NTSB
Bank Accounts: Frozen! (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Bank failures and rescue test Yellen's decades of experience
NYSE:MDT

Medtronic - MDT Stock Forecast, Price & News

$79.37
+1.80 (+2.32%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$77.30
$79.53
50-Day Range
$76.72
$87.58
52-Week Range
$75.76
$114.31
Volume
6.22 million shs
Average Volume
6.36 million shs
Market Capitalization
$105.60 billion
P/E Ratio
26.11
Dividend Yield
3.43%
Price Target
$90.72

Medtronic MarketRank™ Forecast

Analyst Rating
Hold
2.11 Rating Score
Upside/​Downside
14.3% Upside
$90.72 Price Target
Short Interest
Healthy
0.89% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.84
Upright™ Environmental Score
News Sentiment
0.52mentions of Medtronic in the last 14 days
Based on 16 Articles This Week
Insider Trading
Acquiring Shares
$63,429 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Medical Sector

91st out of 989 stocks

Electromedical Equipment Industry

1st out of 24 stocks


MDT stock logo

About Medtronic (NYSE:MDT) Stock

Medtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.

Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.

In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. 

Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. 

Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. 

Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.

Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Stock News Headlines

2 High-Yield Sleep-At-Night Stocks To Buy And Forget About
Verizon and Medtronic are high-yield dividend growers risk-averse investors are flocking to for returns in 2023 and beyond.
Healthcare Stocks With at Least 30 Years of Dividend Increases (MDT)
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
These 11 stocks will be Dividend Kings in 5 years or less. (MDT)
Dividend kings are a popular choice for income investors. Here are some upcoming dividend kings you can consider adding to your portfolio.
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Medtronic plc (NYSE:MDT) Announces Quarterly Dividend of $0.68
Q4 2022 Acutus Medical Inc Earnings Call
Medtronic (NYSE:MDT) Research Coverage Started at StockNews.com
Medtronic: A Smart Dividend Gem To Buy On The Cheap
Medtronic: Slow Growth Makes Me Hesitate To Buy
Medtronic Struggling To Grow Earnings
See More Headlines
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Company Calendar

Ex-Dividend for 1/13 Dividend
12/20/2022
Dividend Payable
1/13/2023
Last Earnings
2/21/2023
Ex-Dividend for 4/14 Dividend
3/23/2023
Today
3/24/2023
Dividend Payable
4/14/2023
Fiscal Year End
4/30/2023
Next Earnings (Estimated)
5/25/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
58505510
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Forecast
$90.72
High Stock Price Forecast
$122.00
Low Stock Price Forecast
$77.00
Forecasted Upside/Downside
+14.3%
Consensus Rating
Hold
Rating Score (0-4)
2.11
Research Coverage
18 Analysts

Profitability

Net Income
$5.04 billion
Pretax Margin
17.60%

Debt

Sales & Book Value

Annual Sales
$31.69 billion
Cash Flow
$7.44 per share
Book Value
$38.80 per share

Miscellaneous

Outstanding Shares
1,330,420,000
Free Float
1,326,566,000
Market Cap
$105.60 billion
Optionable
Optionable
Beta
0.71

Social Links


Key Executives

  • Geoffrey Straub Martha
    Chairman & Chief Executive Officer
  • Megan Fulton Riddle
    Vice President
  • Gregory L. Smith
    Executive VP-Global Operations & Supply Chain
  • Karen L. ParkhillKaren L. Parkhill
    Chief Financial Officer & Executive Vice President
  • Laura Mauri
    CSO, Chief Medical & Regulatory Officer, Senior VP













MDT Stock - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 14 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings
or view top-rated stocks.

What is Medtronic's stock price forecast for 2023?

18 equities research analysts have issued 1 year price targets for Medtronic's stock. Their MDT share price forecasts range from $77.00 to $122.00. On average, they anticipate the company's stock price to reach $90.72 in the next twelve months. This suggests a possible upside of 14.3% from the stock's current price.
View analysts price targets for MDT
or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2023?

Medtronic's stock was trading at $77.72 at the start of the year. Since then, MDT stock has increased by 2.1% and is now trading at $79.37.
View the best growth stocks for 2023 here
.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 25th 2023.
View our MDT earnings forecast
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) announced its quarterly earnings data on Tuesday, February, 21st. The medical technology company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.03. The medical technology company had revenue of $7.70 billion for the quarter, compared to analyst estimates of $7.53 billion. Medtronic had a trailing twelve-month return on equity of 13.37% and a net margin of 13.20%. The company's quarterly revenue was down .8% on a year-over-year basis. During the same period in the previous year, the company earned $1.37 EPS.
Read the conference call transcript
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Thursday, March 2nd. Shareholders of record on Friday, March 24th will be paid a dividend of $0.68 per share on Friday, April 14th. This represents a $2.72 dividend on an annualized basis and a dividend yield of 3.43%. The ex-dividend date of this dividend is Thursday, March 23rd.
Read our dividend analysis for MDT
.

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 3.35%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 89.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 51.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY23 earnings guidance on Tuesday, February, 21st. The company provided earnings per share (EPS) guidance of $5.28-$5.30 for the period, compared to the consensus earnings per share estimate of $5.27.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by many different retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (2.05%), JPMorgan Chase & Co. (1.51%), Franklin Resources Inc. (1.42%), Morgan Stanley (1.35%), Deutsche Bank AG (1.25%) and Moneta Group Investment Advisors LLC (1.06%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Plc Medtronic, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends
.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $79.37.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $105.60 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.04 on an earnings per share basis.

How many employees does Medtronic have?

The company employs 95,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 3/25/2023 by MarketBeat.com Staff